Abstract
Hypertension and cardiovascular events continue to constitute the leading global diseases affecting around 20% of the world’s population. Although there have been significant advances in the treatment and prevention of these diseases, important efforts are being made aiming at deciphering the outstanding issues in the areas of cardiovascular physiology and pathology, positively impacting the development of new strategies applied to the diagnosis and treatment of hypertension. In this search, many animal models of disease have been developed and are currently being employed, demonstrating a most valuable tool in understanding the biological bases of the disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ (2002) Selected major risk factors and global and regional burden of disease. Lancet 360:1347–1360
Phillips MI, Schmidt-Ott KM (1999) The discovery of Renin 100 years ago. News Physiol Sci 14:271–274
Goldblatt H, Weinstein H, Kahn JR (1941) Studies on experimental hypertension: Xiv. The effect of intermittent renal arterial occlusion on the blood pressure of the dog. J Exp Med 73:439–451
Pinto YM, Paul M, Ganten D (1998) Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovasc Res 39:77–88
Bader M (2010) Rat models of cardiovascular diseases. Methods Mol Biol 597:403–414
Osborn JW, Fink GD (2010) Region-specific changes in sympathetic nerve activity in angiotensin II-salt hypertension in the rat. Exp Physiol 95:61–68
Hainsworth AH, Markus HS (2008) Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. J Cereb Blood Flow Metab 28:1877–1891
Yagil Y, Yagil C (1998) Genetic basis of salt-susceptibility in the Sabra rat model of hypertension. Kidney Int 53:1493–1500
Laragh JH (1991) On the mechanisms and clinical relevance of one-kidney, one-clip hypertension. Am J Hypertens 4:541S–545S
Simon G, Abraham G, Cserep G (1995) Pressor and subpressor angiotensin II administration. Two experimental models of hypertension. Am J Hypertens 8:645–650
Schenk J, McNeill JH (1992) The pathogenesis of DOCA-salt hypertension. J Pharmacol Toxicol Methods 27:161–170
Jover B, Mimran A (2001) Nitric oxide inhibition and renal alterations. J Cardiovasc Pharmacol 38(Suppl 2):S65–S70
Trippodo NC, Frohlich ED (1981) Similarities of genetic (spontaneous) hypertension. Man and rat. Circ Res 48:309–319
Okamoto K, Tabei R, Fukushima M, Nosaka S, Yamori Y (1966) Further observations of the development of a strain of spontaneously hypertensive rats. Jpn Circ J 30:703–716
Bianchi G, Ferrari P, Cusi D, Salardi S, Guidi E et al (1986) Genetic and experimental hypertension in the animal model-similarities and dissimilarities to the development of human hypertension. J Cardiovasc Pharmacol 8(Suppl 5):S64–S70
Julien C, Bertolino S, Medeiros IA, Barres C, Sassard J (1997) Renin secretion in Lyon hypertensive rats. Clin Exp Hypertens 19:699–711
Ledingham JM, Laverty R (1998) Renal afferent arteriolar structure in the genetically hypertensive (GH) rat and the ability of losartan and enalapril to cause structural remodelling. J Hypertens 16:1945–1952
Rapp JP, Dene H (1985) Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension 7:340–349
Yagil C, Katni G, Rubattu S, Stolpe C, Kreutz R et al (1996) Development, genotype and phenotype of a new colony of the Sabra hypertension prone (SBH/y) and resistant (SBN/y) rat model of slat sensitivity and resistance. J Hypertens 14:1175–1182
Mullins JJ, Peters J, Ganten D (1990) Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344:541–544
Ganten D, Wagner J, Zeh K, Bader M, Michel JB et al (1992) Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc Natl Acad Sci USA 89:7806–7810
Kantachuvesiri S, Fleming S, Peters J, Peters B, Brooker G et al (2001) Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease. J Biol Chem 276:36727–36733
Kimura S, Mullins JJ, Bunnemann B, Metzger R, Hilgenfeldt U et al (1992) High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J 11:821–827
John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB et al (1995) Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267:679–681
Lopez MJ, Wong SK, Kishimoto I, Dubois S, Mach V et al (1995) Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378:65–68
Chan JC, Knudson O, Wu F, Morser J, Dole WP et al (2005) Hypertension in mice lacking the proatrial natriuretic peptide convertase corin. Proc Natl Acad Sci USA 102:785–790
Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH et al (1996) Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 93:13176–13181
Kandlikar SS, Fink GD (2011) Mild DOCA-salt hypertension: sympathetic system and role of renal nerves. Am J Physiol Heart Circ Physiol 300:H1781–H1787
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Campos, L.A., Baltatu, O.C. (2012). Models of Hypertension and Blood Pressure Recording. In: Szallasi, A., Bíró, T. (eds) TRP Channels in Drug Discovery. Methods in Pharmacology and Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-095-3_5
Download citation
DOI: https://doi.org/10.1007/978-1-62703-095-3_5
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-094-6
Online ISBN: 978-1-62703-095-3
eBook Packages: Springer Protocols